13 Results for "

Fmoc-KCRGDK

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "Fmoc-KCRGDK" in MCE Product Catalog:

Cat. No.: HY-P10715
Target:  

Peptides

Research Areas:  

Inflammation/Immunology Cancer

Fmoc-KCRGDK is a self-assembling peptide that can be used to prepare hydrogels and assist in drug delivery for immune checkpoint inhibitors. Fmoc-KCRGDK can be applied in cancer immunotherapy research .
loading...
    loading...
Cat. No.: HY-41189
CAS No.: 863971-53-3
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Fmoc-Val-Cit-PAB-PNP has superior plasma stability comparable to that of non-cleavable linkers .
loading...
    loading...
Cat. No.: HY-P11295
CAS No.: 3035272-00-2
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-GGFG-PAB-PNP is an ADC linker used in the synthesis of antibody-drug conjugates (ADC) .
loading...
    loading...
Cat. No.: HY-W019682
CAS No.: 84889-09-8
Research Areas:  

Cancer

Fmoc-FF is a building block. Fmoc-FF-prepared hydrogels and nanogels selectively deliver Dexamethasone (HY-14648) to leukemia cells .
loading...
    loading...
Cat. No.: HY-P5037
CAS No.: 185213-75-6
Target:  

Peptides

Research Areas:  

Others

Fmoc-Gly-Pro-Hyp-OH is a tripeptide that can be used in peptide synthesis .
loading...
    loading...
Cat. No.: HY-P5962
Target:  

Peptides

Research Areas:  

Others

Fmoc-Gly-Pro-Hyp(OtBu)-OH (TFA) is a tripeptide that can be used in peptide synthesis .
loading...
    loading...
Cat. No.: HY-P5045
CAS No.: 133575-43-6
Research Areas:  

Inflammation/Immunology Cancer

Fmoc-Thr(GalNAc(Ac)3-β-D)-OH inhibits cancer cell growth, through targeting intricate cancer-specific pathways while simultaneously strengthening immunologic response .
loading...
    loading...
Cat. No.: HY-P3448S
Synonyms: CEND-1-13C6,15N2; iRGD-13C6,15N2; LSTA1-13C6,15N2
Certepetide- 13C6, 15N2 (CEND-1- 13C6, 15N2) is the 13C- and 15N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .
loading...
    loading...
Cat. No.: HY-W1050525
CAS No.: 2377585-15-2
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Val-Ala-Gly (compound 58a) is a cleavable ADC linker, can be conjugated to the antibody Trastuzumab (HY-P9907) to form an antibody-drug conjugate (ADC) .
loading...
    loading...
Cat. No.: HY-P5037A
Target:  

Peptides

Research Areas:  

Others

Fmoc-Gly-Pro-Hyp-OH TFA is a tripeptide that can be used in peptide synthesis .
loading...
    loading...
Cat. No.: HY-P3448S1
Synonyms: CEND-1-13C2,15N; iRGD-13C2,15N; LSTA1-13C2,15N
Certepetide- 13C2, 15N (CEND-1- 13C2, 15N) is the 13C- and 15N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .
loading...
    loading...
Cat. No.: HY-P11504
CAS No.: 3109821-26-0
Research Areas:  

Others

Fmoc-Lys-Gly-Dopa-OH is a tripeptide. Fmoc-Lys-Gly-Dopa-OH forms coacervates in aqueous solution via phase separation. Fmoc-Lys-Gly-Dopa-OH coacervates, with the assistance of Fe 3+, provide a viable material to engineer the surface of mammalian cells .
loading...
    loading...
Cat. No.: HY-P4613
CAS No.: 130674-54-3
Research Areas:  

Others

Fmoc-D-allo-Thr-OH is a derivative of D-allothreonine (HY-W001959), which is commonly used as a building block in solid-phase peptide synthesis (SPPS) .
loading...
    loading...
  • 1